2012-12-05 03:02:55 - Cephalon, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report - a new company profile report on companiesandmarkets.com

Cephalon, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, swot analysis, business description, and company history.

Summary

This report is a crucial resource for industry executives and anyone looking to access key information about Cephalon, Inc.

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

- Examines and identifies key information and issues about Cephalon, Inc. for business intelligence requirements.
- Studies

 

 

and presents the company´s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile also contains information on business operations, company history, major products and services, locations and subsidiaries.

Reasons To Buy

- Quickly enhance your understanding of Cephalon, Inc.
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors´ businesses better.
- Recognize potential partnerships and suppliers.

Key Highlights

Cephalon, Inc. (Cephalon), is a biopharmaceutical company that specializes in the research, development and marketing of innovative therapeutic products. The company develops products for the treatment of cancer, pain, central nervous system (CNS), and inflammatory disease. Its product portfolio includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, tiagabine hydrochloride , modafinil , oral transmucosal fentanyl citrate and cyclobenzaprine hydrochloride extended release capsules. Cephalon has operations in the US, Europe, the Middle East and Africa and offers more than 150 branded and generic products in 100 countries. Cephalon is a subsidiary of Teva Pharmaceutical Industries Ltd. Cephalon is headquartered in Frazer, Pennsylvania, the US.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.